Switch to:

Denali Therapeutics Interest Coverage

: N/A (As of Jun. 2019)
View and export this data going back to 2017. Start your Free Trial

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. Denali Therapeutics's Operating Income for the three months ended in Jun. 2019 was $-62.8 Mil. Denali Therapeutics's Interest Expense for the three months ended in Jun. 2019 was $0.0 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies interest coverage is at least 5. Denali Therapeutics Inc has enough cash to cover all of its debt. Its financial situation is stable.

NAS:DNLI' s Interest Coverage Range Over the Past 10 Years
Min: No Debt   Max: No Debt
Current: N/A


NAS:DNLI's Interest Coverage is ranked lower than
99.99% of the 320 Companies
in the Biotechnology industry.

( Industry Median: 249.19 vs. NAS:DNLI: N/A )

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Denali Therapeutics Interest Coverage Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Interest Coverage 0.00 No Debt No Debt No Debt

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Interest Coverage Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt N/A N/A

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics Interest Coverage Distribution

* The bar in red indicates where Denali Therapeutics's Interest Coverage falls into.



Denali Therapeutics Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1*Operating Income/Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt.


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Denali Therapeutics's Interest Coverage for the fiscal year that ended in Dec. 2018 is calculated as

Here, for the fiscal year that ended in Dec. 2018, Denali Therapeutics's Interest Expense was $0.0 Mil. Its Operating Income was $-46.4 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.0 Mil.

Denali Therapeutics had no debt.

Denali Therapeutics's Interest Coverage for the quarter that ended in Jun. 2019 is calculated as

Here, for the three months ended in Jun. 2019, Denali Therapeutics's Interest Expense was $0.0 Mil. Its Operating Income was $-62.8 Mil. And its Long-Term Debt & Capital Lease Obligation was $70.9 Mil.

GuruFocus does not calculate Denali Therapeutics's interest coverage with the available data.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

The higher the ratio, the stronger the company's Financial Strength is.


Denali Therapeutics  (NAS:DNLI) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Denali Therapeutics Interest Coverage Related Terms


Denali Therapeutics Interest Coverage Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)